These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 28849386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hidden figures: Revisiting doping prevalence estimates previously reported for two major international sport events in the context of further empirical evidence and the extant literature.
    Petróczi A, Cruyff M, de Hon O, Sagoe D, Saugy M.
    Front Sports Act Living; 2022; 4():1017329. PubMed ID: 36544544
    [Abstract] [Full Text] [Related]

  • 5. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B, Kazlauskas R.
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized response estimates for doping and illicit drug use in elite athletes.
    Striegel H, Ulrich R, Simon P.
    Drug Alcohol Depend; 2010 Jan 15; 106(2-3):230-2. PubMed ID: 19740612
    [Abstract] [Full Text] [Related]

  • 8. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER, Kim TY.
    Uisahak; 2014 Aug 15; 23(2):269-318. PubMed ID: 25223222
    [Abstract] [Full Text] [Related]

  • 9. Worldwide distribution of blood values in elite track and field athletes: Biomarkers of altered erythropoiesis.
    Robinson N, Saugy J, Schütz F, Faiss R, Baume N, Giraud S, Saugy M.
    Drug Test Anal; 2019 Apr 15; 11(4):567-577. PubMed ID: 30345707
    [Abstract] [Full Text] [Related]

  • 10. 2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
    Robinson N, Dollé G, Garnier PY, Saugy M.
    Bioanalysis; 2012 Jul 15; 4(13):1633-43. PubMed ID: 22831479
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M, Wagner U.
    Int J Drug Policy; 2013 Nov 15; 24(6):579-88. PubMed ID: 23582632
    [Abstract] [Full Text] [Related]

  • 15. The use of drugs and nutritional supplements in top-level track and field athletes.
    Tscholl P, Alonso JM, Dollé G, Junge A, Dvorak J.
    Am J Sports Med; 2010 Jan 15; 38(1):133-40. PubMed ID: 19812387
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of doping in sports: doping control in Norway, 1977-1995.
    Bahr R, Tjørnhom M.
    Clin J Sport Med; 1998 Jan 15; 8(1):32-7. PubMed ID: 9448955
    [Abstract] [Full Text] [Related]

  • 17. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM, Stewart B.
    Int J Drug Policy; 2015 Jul 15; 26(7):682-7. PubMed ID: 25666447
    [Abstract] [Full Text] [Related]

  • 18. Inadvertent doping through supplement use by athletes: assessment and management of the risk in Australia.
    Baylis A, Cameron-Smith D, Burke LM.
    Int J Sport Nutr Exerc Metab; 2001 Sep 15; 11(3):365-83. PubMed ID: 11591885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.
    Dietz P, Ulrich R, Dalaker R, Striegel H, Franke AG, Lieb K, Simon P.
    PLoS One; 2013 Sep 15; 8(11):e78702. PubMed ID: 24236038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.